Page 4 - Immuron Ltd News Today

Interest rates are once again 0.25% higher than the previous month which will put more strain on individual and family budgets, however, the market has...

Immuron Ltd (ASX:IMC, NASDAQ:IMRN) posted a revenue of $584,000 in H1 FY23, a growth of 153% compared to H1 FY22, with Australian sales contributing...

Market Size – USD 2.04 Billion in 2021, Market Growth – at a CAGR of 16.5%, Market Trends – Implementation of new technologies across the globe

Nonalcoholic Steatohepatitis Therapeutics Market Estimated to Accumulate more than US$ 20.2 Bn by 2031

/PRNewswire/ -- The "Microbiome Global Market Report 2022, Type, Application, Technology" report has been added to ResearchAndMarkets.coms offering. The...

Dublin, Aug. 31, 2022 (GLOBE NEWSWIRE) -- The "Microbiome Global Market Report 2022, Type, Application, Technology" report has been added to...

Human Microbiome Modulators Market Trends – The rise in chronic disease prevalence.

The "Non-Alcoholic Steatohepatitis Treatment Market, by Drug, by Distribution Channel, and by Region Size, Share, Outlook, and Opportunity Analysis, 2022 2030" report has been added to ResearchAndMarkets.com's

The global microbiome therapeutics market is expected to exhibit an exponential CAGR of 62.9% during the forecast period 2018–2025.

/PRNewswire/ -- The "Microbiome Global Market Report 2022: By Type, By Application, By Technology" report has been added to ResearchAndMarkets.coms offering....